๐โ๏ธ Back lately from an incredible journey! #eurotrip โจ
Ticked off some top spots of the #VisitRwanda partners ,the likes of @psg and now the legendary @fcbayern (it canโt be councidence ๐ ).
From breathtaking landscapes to lively markets, Rwanda truly has it all! ๐ธ๐ spilled the beans about Rwanda to my euro amigos for all the beautiful Places ๐ฆ๐ฆ๐ฆhope i convinced them enough to visit ๐ !
Note : this is a personal reflection not affiliated with mentioned partners.
#visitrwanda ๐ท๐ผ
#PSG #fcbayern #harrykanefanpage
Several e-posters presented at #ISMICS2026 focused on challenging aortic surgery through a RAT
๐น David procedure
๐น Bentall procedure
๐น Redo AVR after minimally invasive CABG
Proud to share our experience with these complex minimally invasive procedures. Links in the comments
I sorta had a tiny little hunch this crew would gel brilliant during the mission when @Astro_Christina started mocking my weekly updates during training. This one from @NASAKennedy back in December ๐
During CAG, if you see coronary collaterals to the lungs suspect CTEPH as the cause for effort dyspnoea in patients with very poor echo window where echo evaluation might have been improper. Pre CAG X-ray may give enough clue for it.
Answer: D. At least 45 days
After implantation of the WATCHMAN device using femoral vein access and transseptal catheterization, anticoagulation with warfarin is recommended for at least 45 days, at which time anticoagulation can be discontinued if there is no TEE evidence of peridevice flow.
Reference: Braunwaldโs Heart Disease, Textbook of Cardiovascular Medicine
Additional insight:
Recent evidence from the New England Journal of Medicine comparing left atrial appendage closure with physician-directed medical therapy in high-risk atrial fibrillation patients showed:
โซLAA closure did not achieve noninferiority compared with optimal medical therapy (including DOACs)
โซThe composite outcome (stroke, systemic embolism, major bleeding, or cardiovascular death) was not significantly better with device therapy
โซAdverse events were slightly higher in the device group
โซThese findings reinforce that optimal medical therapy remains a strong standard, and LAA closure should be selectively used, especially when anticoagulation is not feasible
https://t.co/AXmAsvGjt4
Among patients with atrial fibrillation at high risk for stroke and bleeding, left atrial appendage closure was not noninferior to medical therapy in reducing the risk of stroke, embolism, major bleeding, or death at 3 years. Full CLOSURE-AF trial results: https://t.co/qAMC2o36Mi
Editorial: Left Atrial Appendage Closure โ Another Overused Method in Cardiology? https://t.co/KyOWdblUR3
> 600,000 left atrial appendage devices have been placed
NOT NONINFERIOR ๐๐ป
Trial is large, nonindustry funded and done in experienced centers in Germany
Endpoint had both efficacy and safety components and still did not make non-inferiority
I tried to tell you all
@GaindeYi Nah ๐๐ฅโฆ winning finals on paper now? Keep it.
Senegal donโt do imaginary trophies
real champions prove it on the pitch ๏ฟฝ๏ฟฝ๏ฟฝ๐ธ๐ณ
@CAF_Media Nah ๐๐ฅโฆ winning finals on paper now? Keep it.
Senegal donโt do imaginary trophies
real champions proved it on the pitch ๐ช๐ธ๐ณ
@SkySportsNews Nah ๐๐ฅโฆ winning finals on paper now? Keep it.
Senegal donโt do imaginary trophies
real champions prove it on the pitch ๐ช๐ธ๐ณ
For a patient with hypertension, would you recommend a systolic blood-pressure target of less than 120 mm Hg and or a target of less than 140 mm Hg? Vote on the best option: https://t.co/VZOTAyMYAo